Attentional bias in paranoia: systematic review and meta-analysis. [PDF]
Eid L +5 more
europepmc +1 more source
SN/VTA neuromelanin signal is associated with subclinical paranoia irrespective of familial risk for psychosis. [PDF]
Hamati R +5 more
europepmc +1 more source
Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study. [PDF]
Suri RK +3 more
europepmc +1 more source
Case report: the challenges of psychogenic polydipsia. [PDF]
Raha A, Mordekar A.
europepmc +1 more source
Choroidal Vascularity Index in Schizophrenia Compared to Healthy Subjects: A Cross-Sectional Study. [PDF]
Shariati MM +3 more
europepmc +1 more source
A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms. [PDF]
Horan WP +12 more
europepmc +1 more source
Differentially expressed mRNAs of neural signaling pathway genes in peripheral blood leukocytes as biomarkers for schizophrenia. [PDF]
Zhou Y +6 more
europepmc +1 more source
Understanding the Impact of Neighborhood Characteristics on Psychosis Risk Outcomes Through Shared and Distinct Pathways. [PDF]
Ku BS, Arrant EJ, Walker EF.
europepmc +1 more source
Successful Clozapine Rechallenge in a 40-Year-Old Male Patient With Paranoid Schizophrenia After Clozapine-Associated Myocarditis. [PDF]
Zabel L +5 more
europepmc +1 more source
Effectiveness and Safety of Electroconvulsive Therapy in Adolescents with Schizophrenia and Schizoaffective Disorder: A Clinical Case Series. [PDF]
Permoda-Pachuta A +4 more
europepmc +1 more source

